Display Settings:

Format

Send to:

Choose Destination
    Oncology (Williston Park). 1992 Mar;6(3):51-8; discussion 58, 63-6.

    Bone marrow transplantation for genetic disorders.

    Source

    Bone Marrow Transplant Program, Hackensack Medical Center, New Jersey.

    Abstract

    Allogeneic bone marrow transplantation has been successfully utilized to correct the lymphoid and/or hematopoietic abnormalities characterizing a wide array of lethal genetic disorders. Examples include severe combined immunodeficiency, Wiskott-Aldrich syndrome, thalassemia major, sickle cell anemia, and several types of lysosomal storage diseases. Most marrow transplant recipients require preparation with myeloablative doses of chemotherapy, with or without additional radiation therapy, to ensure engraftment of allogeneic marrow. This approach has dramatically changed the long-term outlook for many children with otherwise lethal disorders.

    PMID:
    1533145
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk